← All 95 filings

Anonymous

Public / patientsMember of the publicFiled August 20, 2026374 wordsFDA-2026-N-7874-0023

What they argued

RecovryAI’s one-line reading of the filing.

Q18: 'AI should never be used without human oversight'; 'Post-market review is not enough'; prove accuracy before approval.

Themes it raises

5 of the 21 themes in the docket.
Whether the user can judge the outputFDA Q3, Q4
Trading premarket certainty for postmarket monitoringFDA Q18
How this fits rules that already existFDA Q8, Q9, Q16, Q25
Privacy and protection of patient dataNot asked by the FDA
Harm from an output that was not wrongFDA Q1, Q2

FDA questions it names

Questions this filing names by number.

Q18 · Trading premarket certainty for postmarket monitoring

Coded positions

Where a position was recorded question by question.
Q18Can greater premarket uncertainty about a GenAI device’s benefit-risk profile be accepted through greater reliance on postmarket monitoring?
Do not trade premarket evidence for monitoring

Across the five cross-cutting questions

RecovryAI’s reading of the whole filing. Silence is never counted as opposition.
Patient-facing autonomyShould FDA permit patient-facing AI to act with meaningful autonomy within a defined scope?
Opposes
Proportionate evidenceShould evidence requirements scale with clinical risk rather than a uniform high bar?
No position stated
Postmarket relianceCan strong postmarket monitoring justify accepting more premarket uncertainty?
Opposes
Competency evaluationCan a device be evaluated on competency benchmarks and clinical confirmation against clinicians?
No position stated
Change controlCan devices on third-party foundation models be maintained under pre-specified change control?
No position stated
Autonomy acceptedThe highest level this filing accepts
Low-consequence work: Advises
High-consequence work: Advises
Read and coded by RecovryAI readers, September 12, 2026. The original submission is linked below. Read the filing on regulations.gov ↗
This filing was submitted by a member of the public. We publish our analysis here and link to the submission rather than reproducing it, and this page is not indexed by search engines. Read the full submission on regulations.gov ↗